Immunopathology of the noninfectious posterior and intermediate uveitides

Survey of Ophthalmology

Volumn 46, Issue 3, 2001, Pages 209-233

  Boyd, Shelley Romayne ^a,b   Young, Stephanie ^a   Lightman, Susan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Autoantibody; CD4+ T cells; Choroid; Cytokines; Immunopathology; Uveitis

Indexed keywords

LEUKOCYTE ANTIGEN;

BACTERIUM; BEHCET DISEASE; CHORIORETINOPATHY; CLINICAL EXAMINATION; CLINICAL OBSERVATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HELPER CELL; HISTOPATHOLOGY; HUMAN; IMMUNOGENETICS; IMMUNOPATHOLOGY; INTERMEDIATE UVEITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SYMPATHETIC OPHTHALMIA; UVEITIS; VIRUS; VOGT KOYANAGI SYNDROME;

CYTOKINES; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; T-LYMPHOCYTES, HELPER-INDUCER; UVEITIS, INTERMEDIATE; UVEITIS, POSTERIOR;

EID: 0035658616     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(01)00275-2     Document Type: Review

References (441)

1. Criteria for diagnosis of Behçet's disease
2. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Haradas disease
3. Molecular mimicry and autoimmunity
4. Intermediate uveitis: Epidemiology, age and sex distribution
5. Epidemiological features and visual prognosis of Behçet's disease
6. Immunopathology of ocular sarcoidosis
7. Posterior uveitis as a manifestation of multiple sclerosis
8. Immunological studies on lymphocytes in the cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease and sympathetic ophthalmia
9. Intermediate uveitis: Do HLA antigens play a role?
10. Do HLA antigens play a role in intermediate uveitis?
11. Experimental allergic uveitis
12. The homoimmune uveitises in the guinea pig
13. Familial pars planitis
14. Antibodies to endothelial cells in patients with Behçet's disease
15. Acute posterior multifocal placoid pigment epitheliopathy associated with an adenovirus type 5 infection
16. Histocompatibility antigens in sympathetic ophthalmia
17. Association of birdshot retinochoroidopathy and HLA-A29 antigen
18. Detection of anticytomegalovirus antibody synthesis in the anterior chamber in Vogt-Koyanagi-Harada syndrome
19. Serological and molecular HLA typing in Italian Behçet's patients: Significant association to B51-DR5-DQw3 haplotype
20. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23
21. Behçet's syndrome
22. Basal uveo-retinitis (peripheral uveitis, chronic posterior cyclitis, pars planitis, vitritis, hyalo-retinitis) and other inflammations of the peripheral retina
23. Current and future trends in the use of immunosuppressive agents in patients with uveitis
24. T and B lymphocytes in the aqueous humor of patients with uveitis
25. Colchicine: 1998 Update
26. Histologic and immunopathologic findings in sympathetic ophthalmia
27. Treatment and visual prognosis in Behçet's disease
28. Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behçet disease
29. Serum levels of interleukin-2 receptor in ocular Behçet's disease
30. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis
31. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis
32. Peripheral anergy and local immune hyperactivation in sarcoidosis: A paradox or birds of a feather
33. Multiple sclerosis associated with uveitis in two large clinic-based series
34. Intermediate uveitis of pars planitis type in identical twins. Report of a case
35. HLA antigens and uveitis with special reference to Behçet's disease, chronic herpes simplex, toxoplasmosis, and recurrent acute anterior uveitis
36. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy
37. HLA typing in patients with multiple evanescent white dot syndrome (MEWDS)
38. The prevalence of HLA-B7 in presumed ocular histoplasmosis
39. Intermediate uveitis and Lyme borreliosis
40. Epidemiology of sarcoidosis
41. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome
42. Intermediate uveitis
43. Sympathetic ophthalmia and subretinal neovascularization
44. Birdshot retinochoroidopathy
45. Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease
46. Relationship between sympathetic ophthalmia, phacoanaphylatic endophthalmitis, and Vogt-Koyanagi-Harada disease
47. Granulomas in sympathetic ophthalmia and sarcoidosis. Immunohistochemical study
48. Apoptosis in patients with posterior uveitis
49. Sympathetic ophthalmia. Immunopathological findings
50. Immunopathologic study of Vogt-Koyanagi-Harada syndrome
51. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behçet's disease, and sympathetic ophthalmia
52. Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis
53. CD4+ lymphocyte involvement in ocular Behçet's disease
54. Behçet's disease: Activated T lymphocytes in retinal perivasculitis
55. Multifocal posterior uveitis: Clinical and pathological findings
56. Behçet's disease
57. Lymphocyte stimulation by yeast phase Histoplasma capsulatum in presumed ocular histoplasmosis syndrome
58. Inflammation in the region of the vitreous base. Pars planitis
59. Behçet's disease in Taiwan - A review of 53 cases
60. Acute posterior multifocal placoid pigment epitheliopathy associated with transient hearing loss
61. Bilateral corneal immune ring opacity in Behçet's syndrome
62. Neuro-ophthalmic complications of sarcoidosis
63. Confluent choroidal infiltrates with sarcoidosis
64. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
65. Familial pars planitis
66. Molecular mimicry: Parasite evasion and host defense
67. Prognosticators for visual outcome in sarcoid uveitis
68. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: A randomized double-blind trial
69. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia
70. HLA in intermediate uveitis
71. Immunocytochemical staining of vitreous cells. Indications, techniques, and results
72. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls
73. Cellular immune responses of patients with uveitis to retinal antigens and their fragments
74. HLA-A29 subtypes and birdshot chorioretinopathy
75. Herpes simplex virus and the rheumatic diseases
76. Multiple evanescent white dot syndrome: A genetic predisposition?
77. Acute posterior multifocal placoid pigment epitheliopathy. Pigment epitheliopathy of choriocapillaritis?
78. Immunomodulation of experimental autoimmune uveoretinitis: A model of tolerance induction with retinal antigens
79. Ocular manifestations of immunologic and rheumatologic inflammatory disorders
80. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease
81. Conjunctival deposits as an initial manifestation of sarcoidosis
82. Humoral and cellular immune responsiveness to human S-antigen in uveitis
83. Pars planitis in father and son
84. Sympathetic ophthalmitis
85. Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis
86. Multifocal choroiditis: Clinicopathologic correlation
87. Sympathetic ophthalmia and bilateral phacoanaphylaxis
88. Anti-endothelial cell antibodies in retinal vasculitis
89. A clinical and histopathological review of intermediate uveitis (pars planitis)
90. Studien zur sympatheschen ophthalmie: I. Wirkung von antigen vom augeninnern aus
91. Increased plasma lipoprotein (a) concentrations in Behçet's disease and its relation to vascular events
92. Peripheral blood T cell expansions in patients with Behçet's disease
93. Behçet's disease
94. Optic disc sarcoid granuloma
95. Autoimmunity and the retina
96. Neovascular fundus abnormalities in peripheral uveitis
97. Search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction
98. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis
99. Light and electron microscopic study of Dalen-Fuchs nodules in sympathetic ophthalmia
100. Autoimmunity and autoimmune disease of the eye
101. Immunopathogenic mechanisms in intraocular inflammation
102. The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome
103. Cytokines in human intraocular inflammation
104. The management of Behçet's syndrome
105. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS)
106. Postoperative sympathetic ophthalmia
107. Acute zonal occult outer retinopathy. Donders lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992
108. Vitiliginous chorioretinitis
109. Acute posterior multifocal placoid pigment epitheliopathy
110. Sarcoidosis with optic nerve and retinal involvement
111. Identification of autoantibodies associated with myelin damage in multiple sclerosis
112. Ocular immunopathology of Behçet's disease
113. The day care center: An alternative to institutionalization of the elderly
114. Uveitis in childhood - Part III. Posterior
115. Peripheral uveitis in patients with multiple sclerosis
116. The distribution of melanocytes in the leptomeninges of the human brain
117. Histoplasmic endophthalmitis. A clinicopathologic correlation
118. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome
119. Neovascularisation associated with posterior uveitis
120. Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity
121. Behçet's disease. A report of the ocular histopathology of one case
122. Pars planitis
123. Sympathetic uveitis following evisceration
124. Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung
125. Immunohistology of skin pathergy reaction in Behçet's disease
126. Circulating immune complexes in active Behçet's disease
127. Autoimmunization in the eye
128. Lymphocyte transformation test in sympathetic ophthalmitis and the Vogt- Koyanagi-Harada syndrome
129. Antibodies to herpes simplex virus in patients with Behçet's disease
130. Herpes simplex virus antigens in sera of patients with Behçet's disease
131. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease
132. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease
133. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease
134. Cytotoxic T cells against herpes simplex virus in Behçet's disease
135. Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors
136. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease
137. Activation of autoreactive T cells by peptides from human pathogens
138. Selectin adhesion molecules in Behçet's disease
139. Immunopathogenesis of Behçet's disease
140. Changing patterns of uveitis
141. The significance of the pars plana exudate in pars planitis
142. The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival
143. Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD)
144. Prevalence of Behçet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan
145. Peripheral retinitis and chronic cyclitis in children
146. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases
147. Immune interferon in the circulation of patients with autoimmune disease
148. Anticardiolipin antibodies: Occurrence in Behçet's syndrome
149. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity
150. Ocular manifestations of sarcoidosis
151. Systemic manifestations of sarcoidosis
152. The role of the immune system in uveitis induced in animals
153. The prognosis on Behçet's disease under long period of observation
154. Necrotic changes of choroidal melanocytes in sympathetic ophthalmia
155. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus
156. Pathogenesis of mucocutaneous lesions in Behçet's disease
157. Presumed chronic ocular histoplasmosis syndrome: A clinical-pathologic case report
158. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis
159. Genetic influences on sarcoidosis
160. Platelet aggregation induced by uncommon serotypes of Streptococcus sanguis isolated from patients with Behçet's disease
161. Vogt-Koyanagi-Harada disease in monozygotic twins
162. Interleukin 8 in Behçet's disease
163. Ocular sarcoidosis: Evaluation of intraocular findings
164. Development of scientific studies on industrial hygiene and occupational pathology
165. Ocular involvement in chronic sarcoidosis
166. B- and T-lymphocytes in ocular disease
167. Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy
168. Uveitis. A series of 368 patients
169. Ocular sarcoidosis
170. Description of sarcoidosis: Report of the Subcommittee on Classification and Definition
171. Immunology of sarcoidosis
172. Occlusive retinal arteriolitis with neovascularization
173. Multiple evanescent white dot syndrome. I. Clinical findings
174. MEWDS, MFC, PIC, AMN, AIBSE, and AZOOR: One disease or many?
175. Chronic cyclitis in children
176. Gamma delta T cells, their T cell receptor usage and role in human diseases
177. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies
178. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome
179. Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behçet's disease
180. Birdshot retinochoroidopathy
181. Recurrent clinical uveitis. Cell surface markers on vitreous lymphocytes
182. Ophthalmic changes in sarcoidosis
183. Phenotypes of conjunctival inflammatory cells in sarcoidosis
184. Adamantiades-Behçet's disease: Serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate
185. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
186. Risk factors for uveitis in sarcoidosis
187. Clonally accumulating T cells in the anterior chamber of Behçet disease
188. Sarcoidosis involving the optic nerve head
189. Resolution of optic disk neovascularization associated with intraocular inflammation
190. Histopathology of presumed ocular histoplasmosis
191. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland
192. Sympathetic ophthalmia risk following vitrectomy: Should we counsel patients?
193. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans
194. Microsatellite polymorphism within the MICB gene among Japanese patients with Behçet's disease
195. Granulomatous choroiditis in a case of disseminated histoplasmosis. Histologic demonstration of Histoplasma capsulatum in choroidal lesions
196. Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis
197. Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease
198. Longitudinal study of serum antibody response to bovine corneal protein (BCP 54) in Behçet's disease
199. Immunomodulation of experimental autoimmune diseases via oral tolerance
200. Is A29, B12 vasculitis caused by the Q fever agent? (Coxiella burnetii)
201. Autoimmunity and diabetes
202. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease
203. Sympathetic ophthalmia: A comparison of the histopathological features from a Chinese and American series
204. Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia
205. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B- derived peptide cross-reactive with retinal-S antigen in patients with uveitis
206. Cyclosporine in the treatment of birdshot retinochoroidopathy
207. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease
208. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
209. Determinant spreading and the dynamics of the autoimmune T-cell repertoire
210. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease
211. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome
212. Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy
213. HLA-A29.2 subtype associated with birdshot retinochoroidopathy
214. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi- Harada syndrome
215. Sympathetic ophthalmia in Canada
216. Multiple evanescent white dot syndrome in older patients
217. Peripheral lymphocyte subsets in patients with Vogt-Koyanagi-Harada syndrome (VKH)
218. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of cases (1913-1978)
219. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome
220. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harada disease that recognize human melanoma cells
221. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis
222. Long-term visual outcome and complications associated with pars planitis
223. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis
224. Recent advances in sympathetic ophthalmia
225. Lymphocyte-stimulating activity of ocular tissues in sympathetic ophthalmia
226. Granulomatous uveitis after treatment of a choroidal melanoma with proton-beam irradiation
227. The role of chorioretinal biopsy in the management of posterior uveitis
228. Association of intermediate uveitis with HLA-A28: Definition of a new systemic syndrome?
229. A nationwide survey of Behçet's disease in Japan
230. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease
231. Electron microscopic studies on Vogt-Koyanagi-Harada syndrome and sympathetic ophthalmia with special reference to the melanocyte
232. Clinical entities in uveitis: An approach to the study of intraocular inflammation
233. Vogt-Koyanagi-Harada syndrome - Isolation of cloned T cells with specificity for melanocytes and melanoma cells
234. Mycobacteria as possible causes of sarcoidosis and Crohns disease
235. Ocular histoplasmosis: Clinicopathologic correlation of 3 cases
236. Association of HLA-DRw2 antigen with presumed ocular histoplasmosis
237. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung
238. The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD Behçet's disease in Japan: Ophthalmologic aspects
239. Sarcoidosis
240. Sarcoidosis: Histopathological definition and clinical diagnosis
241. Histopathological findings in proliferative membrane from a patient with sarcoid uveitis
242. Molecular genetics (HLA) of Behçet's disease
243. Immunogenetic studies of Behçet's disease
244. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease
245. Immunotherapy for Behçet's disease
246. Uveitis associated with human T-cell lymphotropic virus type I
247. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice
248. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis
249. Vogt-Koyanagi-Harada syndrome
250. Virus search in cerebrospinal fluid in Vogt-Koyanagi syndrome: Report of a case
251. Crossregulation between Th1 and Th2 cells
252. Virus-like inclusion bodies in subretinal fluid in uveo-encephalitis
253. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
254. Behçet's disease in Japan and in Great Britain: A comparative study
255. Ocular vasculitis in Behçet's disease. A pathological and immunohistochemical study
256. Early stage of human sympathetic ophthalmia. Histologic and immunopathologic findings
257. Sarcoidosis: Immunopathogenetic concepts and their clinical application
258. Melanin-laden macrophages in cerebrospinal fluid in Vogt-Koyanagi-Harada syndrome
259. Behçet's disease and streptococcal infection
260. Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease
261. Analysis of responses of peripheral blood lymphocytes from sarcoidosis patients to purified protein derivative
262. Antiretinal autoantibodies in intermediate uveitis
263. Vitrectomy in multifocal chorioretinitis
264. Cellular phenotype of vitreous cells in intermediate uveitis
265. Peripheral multifocal chorioretinitis with panuveitis: Clinical and immunogenetic characterization in older patients
266. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease
267. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease
268. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease
269. Proctor Lecture. Experimental autoimmune uveitis: Mechanisms of disease and clinical therapeutic indications
270. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen
271. Sarcoidosis and its ophthalmic manifestations
272. Ocular sarcoidosis
273. Summary of the Third International Conference on Behçet's Disease
274. A case of proliferative sarcoid retinopathy with sarcoid nodules in tissue obtained during vitrectomy
275. T cell selection and autoimmunity: Flexibility and tuning
276. Immunological aspects of Behçet's and Vogt-Koyanagi-Haradas diseases
277. Behçet's disease in the world: Recent advances in Behçet's disease. International congress and symposium series no 103 London
278. HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis
279. Studies on spontaneous production of gamma-interferon in Behçet's disease
280. Clinical studies of Vogt-Koyanagi-Haradas disease
281. Close association of HLA-Bw51 with Behçet's disease
282. T lymphocyte subsets in aqueous humor from patients with uveitis
283. Expression of Fas antigen on helper T lymphocytes in Vogt-Koyanagi-Harada disease
284. Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease
285. Surface marker studies of cerebrospinal fluid lymphocytes in Vogt- Koyanagi-Harada diseases
286. Validation of the International Study Group criteria for Behçet's disease
287. Birdshot retinochoroiditis
288. Ocular manifestations of cat-scratch disease
289. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping
290. Histopathology of the subretinal fibrosis and uveitis syndrome
291. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation
292. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis
293. T cell-dependent B cell activation
294. Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis
295. Redirecting Th1 and Th2 responses in autoimmune disease
296. Pathology of pars planitis
297. Uveitis in London and Iowa
298. Markers of vascular injury in Behçet's disease associated with retinal vasculitis
299. White-dot chorioretinal inflammatory syndromes
300. Epithelioid cell granulomatosis of the lung: New insights and concepts
301. Sarcoidosis among the Chinese and a review of the worldwide epidemiology of sarcoidosis
302. Pars planitis: Clinical features and class II HLA associations
303. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome
304. Vogt-Koyanagi-Harada syndrome after cutaneous injury
305. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern
306. Considerations anciennes et nouvelles sur la pathologie at la pathogenie de lophthalmie sympathique
307. Histocompatibility antigens in sympathetic ophthalmia
308. Behçet's disease: An immune-mediated vasculitis involving vessels of all sizes
309. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis
310. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
311. T-cell subsets (Th1 versus Th2)
312. Th1/Th2 cells
313. The Th1/Th2 paradigm
314. Human TH1 and TH2 subsets: Doubt no more
315. Ocular involvement in sarcoidosis
316. Risk factors for ocular sarcoidosis
317. The end stage of birdshot retinochoroidopathy
318. The current state of multiple sclerosis genetic research
319. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome
320. Histopathological correlates of presumed ocular histoplasmosis
321. Birdshot retinochoroidopathy
322. Acute posterior multifocal placoid pigment epitheliopathy
323. Genetics of sarcoidosis
324. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction
325. Pharmacotherapy for Behçet's syndrome
326. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease
327. Functional aberration of T cell subsets in patients with Behçet's disease
328. Etiopathology of Behçet's disease: Immunological aspects
329. Novel approaches to Behçet's disease
330. Drug treatments for skin disease introduced in 1999
331. Behçet's disease
332. Epidemiology of sarcoidosis in the U.S. Navy
333. Induction of unresponsiveness in adult rats by immunodominant and nondominant peptides
334. Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides
335. Cytokines in Behçet's disease
336. Behçet's disease in the Middle East
337. Eye histoplasmosis
338. Further investigations for the demonstration of a specific microorganism in sympathetik ophthalmia
339. The functional role of CD8+ T helper type 2 cells
340. Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis
341. Immunohistological study in sarcoidosis: Evaluation at different sites of disease activity
342. Inflammatory cellular kinetics in sympathetic ophthalmia: A study of traumatized (exciting) eyes
343. Sarcoidosis
344. Circulating gamma delta-T-cell-receptor-positive lymphocytes in sarcoidosis
345. Genome sequencing analysis of the 1.8 Mb entire human MHC class I region
346. Haradas, Behçet's, Vogt-Koyanagi syndromes--are they clinical entities?
347. Immunogenetic study of sympathetic ophthalmia
348. Course and prognosis of sarcoidosis around the world
349. Reduction of cyclosporine dosage with ketoconazole in a patient with birdshot retinochoroidopathy
350. Experimental autoimmune uveitis as animal model for human posterior uveitis
351. The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy
352. Association of HLA B8 with spontaneous resolution in sarcoidosis
353. Complications of chronic cyclitis
354. Chronic cyclitis. I. Course and visual prognosis
355. Vogt-Koyanagi-Harada syndrome
356. Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease
357. Multiple evenescent white dot sydrome
358. Soluble Fas ligand expression in the ocular fluids of uveitis patients
359. Lack of the HLA-DR2 specificity in multifocal choroiditis and panuveitis
360. Epstein-Barr virus antibodies in multifocal choroiditis and panuveitis
361. Fundus changes in histologically confirmed sarcoidosis
362. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome
363. Sarcoidosis
364. Regional immunity and ocular immune privilege
365. General principles of immuno-ophthalmology
366. Immunoregulatory mechanisms of the eye
367. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease
368. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
369. Vogt-Koyanagi-Harada disease
370. Coats-like response in pars planitis
371. Epstein-Barr virus-related antibody pattern in uveitis
372. Birdshot chorioretinopathy and Lyme borreliosis
373. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease
374. Vogt-Koyogani-Harada syndrome
375. HLA-A29 sub-types and Birdshot choroido-retinopathy susceptibility: A possible resistance motif in the HLA-A29.1 molecule
376. Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt-Koyanagi-Harada disease (authors transl)
377. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice
378. Molecular biological analysis of retinal and streptococcal heat-shock protein 60
379. Behçet's disease and antibody titers to various heat-shock protein 60s
380. Common antigenicity between Yersinia enterocolitica-derived heat-shock protein and the retina, and its role in uveitis
381. The association of HLA-DR15 and intermediate uveitis
382. Pars planitis in a family
383. Gedanken uber den ausbruch der sympathetischem ophthalmie
384. Epstein-Barr viral antibodies in multifocal choroiditis and panuveitis
385. Sympathetic ophthalmia
386. Sympathetic ophthalmia
387. Visual prognosis in Behçet's disease
388. Immunopathologic study of the conjunctiva in patients with Behçet disease
389. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt- Koyanagi-Haradas disease
390. Gamma delta T cells in peripheral blood and in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis
391. Search for autoantibodies against the HNK-1 carbohydrate epitope in the human eye in intermediate uveitis
392. Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies
393. Role of the allergist in diagnosis and management of patients with uveitis
394. Epitope spreading
395. Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease
396. Factor V Leiden mutation is associated with ocular involvement in Behçet disease
397. Soluble adhesion molecules in Behçet's disease
398. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease
399. Experimental allergic uveitis. I. Production in the guinea pig and rabbit by immunization with retina in adjuvant
400. Experimental allergic uveitis: Homologous retina as uveitogenic antigen
401. MIC-A allele profiles and HLA class I associations in Behçet's disease
402. Histoplasmosis-like choroiditis in a nonendemic area: The northwest United States
403. Punctate inner choroidopathy
404. Presumed ocular histoplasmosis syndrome
405. Clinical and immunopathological studies of pars planitis in a family
406. Immunologic mechanisms of uveitis. New targets for immunomodulation
407. Immune complexes in Behçet's syndrome and recurrent oral ulceration
408. Gamma/delta cells in tissue from patients with sarcoidosis
409. The ocular pathology of Behçet's disease
410. Uveitis in childhood
411. Acute, posterior, multifocal, placoid, pigment epitheliopathy and Lyme disease
412. HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy
413. Sympathetic ophthalmia and lymphocyte transformation
414. Behçet's syndrome in HLA-identical siblings
415. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
416. Immunogenetics and uveitis
417. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece
418. S-antigen specific T cell clones from a patient with Behçet's disease
419. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease
420. Lymphocyte subsets in erythema nodosum-like skin lesions from patients with Behçet's disease
421. Hyperreactivity of neutrophils and abnormal T cell homeostasis: A new insight for pathogenesis of Behçet's disease
422. Role of gammadelta T lymphocytes in the development of Behçet's disease
423. CD56+ T cells in the peripheral blood of uveitis patients
424. Medical management of Behçet's syndrome
425. Antibody response to oral streptococci in Behçet's disease
426. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis
427. Behçet's disease and streptococcal antigens
428. Pigment epithelial diseases with abnormal choroidal perfusion
429. Epidemiology of sarcoidosis: Ethnic and geographic considerations
430. Sympathetic uveitis 66 years after injury
431. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population
432. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes
433. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes